JACC-Heart Failure

Scope & Guideline

Enhancing Knowledge for Heart Health Professionals

Introduction

Delve into the academic richness of JACC-Heart Failure with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2213-1779
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationJACC-HEART FAIL / JACC-Heart Fail.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'JACC: Heart Failure' focuses on the advancement of knowledge in the field of heart failure through rigorous research and clinical insights. It emphasizes the importance of guideline-directed medical therapy, innovative treatment strategies, and the management of comorbid conditions associated with heart failure.
  1. Heart Failure Management Strategies:
    The journal covers clinical trials and studies focusing on the management of heart failure, including pharmacological interventions, device therapy, and rehabilitation approaches.
  2. Epidemiology and Risk Factors:
    Research on the epidemiology of heart failure, including the identification of risk factors, comorbidities, and social determinants of health that influence patient outcomes.
  3. Innovative Therapies and Technologies:
    Exploration of new therapeutic strategies, including the use of sodium-glucose cotransporter inhibitors, novel devices, and digital health technologies for heart failure management.
  4. Patient-Centered Care:
    Emphasis on the importance of patient-reported outcomes, quality of life assessments, and the integration of patient preferences in heart failure treatment plans.
  5. Guideline-Directed Medical Therapy (GDMT):
    Studies focusing on the implementation, adherence, and optimization of GDMT in diverse populations, including challenges faced in clinical practice.
  6. Health Disparities in Heart Failure:
    Investigation into disparities in heart failure care and outcomes based on race, ethnicity, gender, and socioeconomic status.
Recent publications in 'JACC: Heart Failure' reveal several emerging themes that reflect the evolving landscape of heart failure research, focusing on innovative approaches, personalized medicine, and comprehensive care models.
  1. Digital Health and Telemedicine:
    A significant increase in studies exploring the use of digital health technologies, telemedicine, and remote patient monitoring for managing heart failure, especially post-COVID-19.
  2. SGLT2 Inhibitors and Heart Failure:
    Growing research interest in the application of SGLT2 inhibitors for heart failure management, highlighting their benefits beyond diabetes control and their impact on heart failure outcomes.
  3. Comorbid Conditions and Integrated Care:
    Emerging focus on the management of comorbidities alongside heart failure, particularly in relation to chronic kidney disease, obesity, and mental health, emphasizing a holistic approach to patient care.
  4. Health Equity and Social Determinants of Health:
    Increasing attention on health disparities and social determinants affecting heart failure outcomes, driving research that seeks to address inequities in access to care and treatment.
  5. Personalized Medicine Approaches:
    A trend towards personalized treatment strategies in heart failure, incorporating genetic, phenotypic, and biomarker data to tailor therapies to individual patient needs.

Declining or Waning

While 'JACC: Heart Failure' continues to thrive in many areas of research, certain themes are becoming less prominent in recent publications. These waning scopes reflect shifts in clinical focus and emerging evidence that may influence future research directions.
  1. Traditional Heart Failure Biomarkers:
    Research on conventional biomarkers like BNP and NT-proBNP is seeing a decline as newer, more comprehensive diagnostic approaches and biomarkers gain traction in heart failure management.
  2. Invasive Procedures for Diagnosis and Management:
    There is a noticeable decrease in studies centered on invasive procedures, such as routine cardiac biopsies or catheterizations, as non-invasive and remote monitoring technologies are increasingly preferred.
  3. Single-Factor Studies:
    Research focusing solely on single interventions or factors in heart failure is declining in favor of multi-faceted approaches that consider the complexity of patient care and the interaction of various treatment modalities.

Similar Journals

Egyptian Heart Journal

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: SPRINGERISSN: 1110-2608Frequency: 1 issue/year

The Egyptian Heart Journal, published by Springer, is a premier open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. As of 2023, it holds a Q3 classification within the category, showcasing its growing influence within the research community, and ranks 241 out of 387 in Scopus, reflecting a 37th percentile position. With an E-ISSN of 2090-911X, this journal has been open access since 2011, making it easily accessible to researchers, practitioners, and students alike. The journal aims to disseminate high-quality research articles, reviews, and case studies that contribute to the understanding and treatment of cardiovascular diseases. With its focus on innovative and practical solutions in cardiology, the Egyptian Heart Journal plays a critical role in shaping current and future cardiovascular research. Its global outreach and commitment to open access ensure that vital information is available to a wide audience, enhancing both scholarly discourse and clinical practice in the evolving landscape of cardiovascular medicine.

Current Heart Failure Reports

Elevating Standards in Cardiovascular Health
Publisher: SPRINGERNATUREISSN: 1546-9530Frequency: 6 issues/year

Current Heart Failure Reports, published by SpringerNature, is a leading journal dedicated to advancing the field of cardiology, specifically focusing on heart failure. With an impressive impact factor and a recognized reputation, this journal falls under the top quartiles in several categories, including Q1 in Cardiology and Cardiovascular Medicine and Emergency Medicine. Its range of topics encompasses both clinical and research insights into heart failure management, offering valuable perspectives aligned with the latest therapeutic advancements. Although it does not have open access options, researchers and practitioners can find profound studies and reviews aimed at improving patient care and outcomes in cardiovascular health. As the journal converges towards its 20th year in print, it continues to serve as a critical resource for academic professionals, providing a platform for high-quality research that shapes the future of heart failure treatments.

Journal of the Saudi Heart Association

Exploring Innovations in Cardiology and Patient Care
Publisher: DIGITAL COMMONS BEPRESSISSN: 1016-7315Frequency: 4 issues/year

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

Heart International

Elevating the discourse on heart health with impactful research.
Publisher: TOUCH MEDICAL MEDIA LTDISSN: 2036-2579Frequency: 2 issues/year

Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.

ESC Heart Failure

Innovating the future of heart failure therapies.
Publisher: WILEY PERIODICALS, INCISSN: 2055-5822Frequency: 6 issues/year

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

Netherlands Heart Journal

Fostering Innovation in Heart Health Through Scholarly Discourse
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Revista Portuguesa de Cardiologia

Empowering the fight against heart disease through open access research.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

CIRCULATION

Advancing Cardiovascular Insights, One Beat at a Time.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

CURRENT OPINION IN CARDIOLOGY

Bridging research and practice in the heart of medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0268-4705Frequency: 6 issues/year

CURRENT OPINION IN CARDIOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed journal in the field of cardiology that has been serving the academic community since 1988. With a robust focus on the latest developments and emerging trends in cardiovascular medicine, this journal aims to bridge the gap between clinical practice and research, offering critical insights and expert commentary. The journal is recognized in the medical community, achieving a 2023 Scopus rank of #148 out of 387 in its category, placing it in the 61st percentile. Although it operates under a subscription-based model, CURRENT OPINION IN CARDIOLOGY remains an essential resource for researchers, practitioners, and students seeking cutting-edge knowledge and advancements in cardiology. As a Q2 journal in the field, it continues to foster dialogue and provide a platform for disseminating impactful cardiovascular research, ultimately contributing to improved patient outcomes and informed clinical decisions.

CURRENT PROBLEMS IN CARDIOLOGY

Addressing the Urgent Issues in Cardiology Today
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.